We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INBP market cap is 6.02M. The company's latest EPS is USD -0.0011 and P/E is -181.82.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.98M | 52.77M | 63.56M | 56.25M | 50.67M |
| Operating Income | 2.7M | 3.26M | 5.78M | 2.75M | 120k |
| Net Income | 1.69M | 4.11M | 8.01M | 3.84M | -34k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.79M | 22.94M | 25.44M | 25.25M | 25.43M |
| Total Liabilities | 17.9M | 16.88M | 11.11M | 6.68M | 6.57M |
| Total Equity | 1.89M | 6.07M | 14.33M | 18.58M | 18.86M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 328k | 1.34M | 3.05M | 4.09M | 1.23M |
| Investing | -422k | -110k | -199k | -465k | -111k |
| Financing | 341k | -1.3M | -3.04M | -3.51M | -136k |
| Market Cap | 6.02M |
| Price to Earnings Ratio | -181.82 |
| Price to Sales Ratio | 0.12 |
| Price to Cash Ratio | 4.58 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 30.1M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.77k |
| 52 Week Change | -32.10% |
| 52 Week High | 0.3349 |
| 52 Week Low | 0.17 |
| Spread (Intraday) | 0.03 (13.5%) |
| Company Name | Integrated BioPharma Inc (QX) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ir.ibiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
